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1Department of Microbial Pathogenesis, Yale University, New Haven, United States;
2Microbial Sciences Institute, Yale University, New Haven, United States; 3W.M.
Keck Biotechnology Resource Laboratory, Yale University School of Medicine, New
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Abstract Human gut Bacteroides use surface-exposed lipoproteins to bind and metabolize
complex polysaccharides. Although vitamins and other nutrients are also essential for commensal
fitness, much less is known about how commensal bacteria compete with each other or the host for
these critical resources. Unlike in Escherichia coli, transport loci for vitamin B12 (cobalamin) and
other corrinoids in human gut Bacteroides are replete with conserved genes encoding proteins
whose functions are unknown. Here we report that one of these proteins, BtuG, is a surface-
exposed lipoprotein that is essential for efficient B12 transport in B. thetaiotaomicron. BtuG binds
B12 with femtomolar affinity and can remove B12 from intrinsic factor, a critical B12 transport protein
in humans. Our studies suggest that Bacteroides use surface-exposed lipoproteins not only for
capturing polysaccharides, but also to acquire key vitamins in the gut.
DOI: https://doi.org/10.7554/eLife.37138.001
Introduction
Our understanding of the factors that shape gut microbial community composition is largely based
on the primary economy of this ecosystem: the flow of carbon from the diet to bacterial biomass
and fermentation products. However, an accompanying secondary economy of essential vitamins
and other cofactors, which are much less abundant, also plays a critical role in determining bacterial
growth rates and resulting microbiome dynamics (Sonnenburg and Sonnenburg, 2014). Small mole-
cule cofactor biosynthesis is an energetically costly process and alternate cofactor-independent
enzymes can be less efficient (Roth et al., 1993), favoring microbes that can best acquire these
nutrients from their environment.
The complex organometallic cofactor vitamin B12 (cobalamin) is representative of this challenge:
de novo biosynthesis requires the coordinated activity of nearly 30 dedicated enzymes (Roth et al.,
1993). Although bacteria have evolved cofactor-independent alternatives to many B12-dependent
enzymes (e.g. B12-independent methionine synthase MetE and ribonucleotide reductase NrdEF),
even species that lack vitamin biosynthetic machinery maintain their B12-dependent enzymes (e.g.,
methionine synthase MetH and ribonucleotide reductase NrdZ) for use when vitamin B12 is available
in the environment (Degnan et al., 2014a; Degnan et al., 2014b; Young et al., 2015). In the human
gut, most species encode B12-dependent enzymes. The great majority of these species also encode
transport systems for capturing B12 from the environment, either instead or in addition to vitamin
biosynthetic pathways (Degnan et al., 2014a). Although bacteria utilize many vitamin B12-like mole-
cules (corrinoids), transport and utilization proteins and regulatory elements are typically referred to
as B12-dependent, in keeping with their initial characterization.
The machinery used by Gram-negative bacteria to transport vitamin B12 and other corrinoids has
been studied extensively in Escherichia coli and has been used as a model for TonB-dependent
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transport. In E. coli, extracellular B12 is transported into the periplasm through the outer membrane
b-barrel protein BtuB in a TonB-dependent manner (Bassford et al., 1976; Bassford and Kadner,
1977). The periplasmic protein BtuF subsequently binds to and delivers B12 to the ABC-type trans-
porter BtuCD in the inner membrane, which brings the vitamin into the cytoplasm (Cadieux et al.,
2002).
In previous studies, we established that the most abundant Gram-negative bacteria in the human
gut (Bacteroidetes) encode a diverse array of B12 transport systems in B12-riboswitch regulated loci,
often with multiple locus architectures per genome (Degnan et al., 2014a). Bacteroides thetaioato-
micron serves as a model for defining the role of these transporters, as it does not encode B12 bio-
synthetic machinery, and its repertoire of B12 transporters determine in vivo fitness in a diet- and
community context-dependent manner (Degnan et al., 2014a; Goodman et al., 2009). In the
course of these studies, we noticed that B. thetaiotaomicron and other human gut Bacteroides also
maintain a heterogeneous repertoire of additional genes, nearly all of unknown function, in these
B12 transport loci. E. coli also encodes additional genes within its B12 transport operons (e.g., btuE is
positioned between btuC and btuD), but these do not play a role in B12 transport (de Veaux et al.,
1986; Arenas et al., 2010).
Here we report that unlike BtuE in E. coli, Bacteroides accessory proteins can play a critical role in
B12 transport. Using the B. thetaiotaomicron homolog of a highly conserved accessory protein
(BT1954; hereafter called BtuG2) as a representative, we establish that BtuG2 localizes to the cell
surface, interacts with BtuB, and determines the ability of B. thetaiotaomicron to transport B12 and
persist in the mammalian gut. Furthermore, BtuG2 directly binds vitamin B12 with femtomolar affin-
ity, thereby enabling it to acquire this vitamin from intrinsic factor, a critical B12 transport protein in
humans.
Results
Bacteroidetes btuG homologs display widespread genetic linkage to
vitamin B12 transport genes and facilitate cyanocobalamin acquisition
Nearly all of the Bacteroides B12 transport loci include homologs of a hypothetical gene that is exclu-
sively found in the Bacteroidetes phylum (Figure 1A). We refer to these homologs as BtuG; one of
eLife digest Eating is the first step in an hours-long process that extracts the nutrients we need
to live. It not only nourishes us, but also a vast community of bacteria in our gut called the
microbiota. The gut microbiota acts like an extension of our immune system and helps us stay
healthy in many ways. For example, it blocks pathogens from making us sick. But too many gut
bacteria in the wrong parts of our intestines can be harmful.
Some people are prone to developing a dangerous overgrowth of bacteria in their small intestine
where most of our dietary nutrients get absorbed. This overgrowth can lead to many problems
including vitamin B12 deficiency even when they eat plenty of it. To understand why, scientists must
learn how microbes affect our ability to absorb nutrients from food and how the microbes
themselves capture nutrients like vitamin B12 as they pass through our digestive tract.
Now, Wexler et al. show that some gut microbes may be able to pirate vitamin B12 from us as it
passes through the digestive tract. Wexler et al. showed that a protein called BtuG on the surface of
a type of gut bacteria called Bacteriodes grabs onto vitamin B12 with extraordinary strength. In fact,
these bacterial proteins bind to vitamin B12 so strongly that they can even pry it away from our own
vitamin B12 collecting protein.
When Bacteriodes with and without BtuG were placed in mice with no gut bacteria of their own,
bacteria with BtuG rapidly outcompeted those lacking the protein. The experiments suggest that
competition for vitamin B12 among microbes has favored bacteria that are better at capturing the
nutrient. More studies are needed to learn whether BtuG contributes to vitamin B12 deficiencies in
humans with gut bacteria overgrowth and determine the best ways to combat such deficiencies.
DOI: https://doi.org/10.7554/eLife.37138.002
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which (BtuG2 from B. thetaiotaomicron, marked with a star in Figure 1A) has been crystallized and
adopts a seven-bladed b-propeller fold (PDB 3DSM; Figure 1B). B. thetaiotaomicron encodes three
genetic loci with vitamin B12 transport genes (locus1, locus2 and locus3; Figure 1A). Each locus enc-
odes a btuG homolog (btuG1, btuG2 and btuG3, respectively) adjacent to a homolog of btuB
(Figure 1A). Using BtuG1, BtuG2 and BtuG3 from B. thetaiotaomicron as representatives, we identi-
fied 112 putative BtuG homologs in 313 genome-sequenced human gut bacterial strains
(Degnan et al., 2014a) by an initial BlastP search (Supplementary file 1). 106 are encoded in 106 of
109 btuB-containing operons identified previously (Degnan et al., 2014a). The six remaining btuG
homologs identified by BlastP have operon annotations affected by incomplete genome assemblies,
however, five are associated with a corrinoid riboswitch and one or more btu transport genes. Two
of the three remaining btuB-containing operons encode a divergent btuG gene (e-value >1e-10, but
Phyre2 match to the BtuG2 crystal structure). No homologs were detected outside of the Bacteroi-
detes using the defined BlastP parameters (Supplementary file 1).
We sought to test whether BtuG is needed for B12-dependent growth, given the near universal
genetic linkage of btuG homologs to known B12 transport genes. Because B. thetaiotaomicron enco-
des three homologous B12 transport loci (and corresponding btuG genes) that complicate the ability
to assign functions to specific genes, we established a simplified genetic background that lacks
locus1 and locus3 (hereafter referred to as the B. thetaiotaomicron ‘parent’ strain). We created an
in-frame, unmarked deletion of btuG2 in this parent strain and tested its ability to grow in minimal
media supplemented with cyanocobalamin (B12-dependent growth; B. thetaiotaomicron encodes
MetH but not MetE) or methionine (B12-independent growth). We chose cyanocobalamin concentra-
tions of 37 nM and 0.37 nM because these concentrations repress (37 nM) or activate (0.37 nM) B12
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Figure 1. BtuG homologs are exclusively found among the Bacteroidetes, facilitate the acquisition of cyanocobalamin in vitro and confer a fitness
advantage in gnotobiotic mice. (A) Genetic loci encoding corrinoid transport components in E. coli, B. thetaiotaomicron and other Bacteroidetes. (B)
BtuG2 (PDB 3DSM) adopts a seven-bladed b-propeller fold. (C) Growth curves for the B. thetaiotaomicron parent strain, btuG2 deletion strain or
complemented strain grown in minimal media supplemented with methionine or vitamin B12. Data are representative of three independent trials; error
bars indicate ±SD from three technical replicates. (D) Gene expression ratios for B. thetaiotaomicron strains grown in minimal media with methionine
and indicated concentrations of vitamin B12. Expression of locus2 (BT1956) was normalized first to 16S rRNA and then to each strain’s expression in 0
nM vitamin B12. Data are representative of two independent trials; error bars indicate ± SD from three biological replicates. (E, F) B. thetaiotaomicron
strain ratios determined from gDNA extracted from fecal samples collected over time from gnotobiotic mice. (n.d., not detected; n = 4 mice/group;
error bars indicate ± SD).
DOI: https://doi.org/10.7554/eLife.37138.003
The following figure supplement is available for figure 1:
Figure supplement 1. A BtuG homolog is required for B. thetaiotaomicron fitness in gnotobiotic mice.
DOI: https://doi.org/10.7554/eLife.37138.004
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riboswitches in this species (Sonnenburg et al., 2005; Martens et al., 2008; Degnan et al., 2014a).
As compared with its growth in methionine medium, the btuG2 deletion strain had a ~4 hr longer
lag phase in 37 nM cyanocobalamin medium and did not display any growth during 72 hr in 0.37 nM
cyanocobalamin medium (Figure 1C). By contrast, the parent and complemented strains grew indis-
tinguishably in all three media.
Vitamin B12 riboswitches are RNA aptamers that bind B12 directly and repress downstream gene
expression, providing a biosensor for intracellular levels of this cofactor (Fowler et al., 2010). To
determine the contribution of BtuG2 to intracellular corrinoid accumulation, we used the B12 ribos-
witch of locus2 as a biosensor. Quantification of gene expression by qRT-PCR revealed that the par-
ent strain represses riboswitch-dependent gene expression ~70 fold in culture medium containing
37 nM cyanocobalamin as compared to medium with 0.37 nM and 0 nM cyanocobalamin. By con-
trast, the btuG2 deletion strain fails to repress B12 riboswitch-regulated gene expression in any con-
centration of extracellular cyanocobalamin (Figure 1D). These data suggest that BtuG2 contributes
significantly to B12 accumulation within B. thetaiotaomicron cells.
B12 transport machinery encoded in locus2 are critical for B. thetaiotaomicron fitness in gnotobi-
otic mice (Goodman et al., 2009). To compare the relative contribution of BtuG2 and BtuB2 to fit-
ness in the gut, we colonized germfree mice with a 1:1 mixture of the parent strain and DbtuG2
(Figure 1E and Figure 1—figure supplement 1) or DbtuB2 (Figure 1F), and monitored the relative
abundance of each strain in fecal samples collected over time. In both groups of mice, the parent
strain dominated while the abundance of the mutant strain dropped continuously until it was no lon-
ger detected on day 24 (Figure 1E–F). Surprisingly, these data indicate that the absence of BtuG2
has a similarly deleterious impact on in vivo fitness as the absence of the outer membrane trans-
porter BtuB2. Together, these studies suggest that BtuG plays a critical role in mediating B. thetaio-
taomicron B12 transport in the gut.
BtuG2 is a lipoprotein that localizes to the cell surface and associates
with B12 transport machinery
We next sought to determine the subcellular localization of BtuG2 to better understand its role in
B12 transport. Aligning the first 90 amino acids of 114 homologs of BtuG (Supplementary file 1)
using ClustalW (Larkin et al., 2007) and displaying their conservation as a sequence logo
(Crooks et al., 2004; Schneider and Stephens, 1990) revealed a number of important clues: firstly,
nearly all homologs have a conserved cysteine residue within their first ~18–40 amino acids (Cys-32
of BtuG2) (Inouye et al., 1983); secondly, this cysteine is preceded by a conserved lipobox-like
sequence typical of lipidated proteins (VFGS in BtuG2) (von Heijne, 1989); thirdly, this cysteine is
followed by a conserved lipoprotein export signal or LES (MKWD in BtuG2), a feature exclusive to
Bacteroidetes that allows lipoproteins to be flipped from the inner to the outer leaflet of the outer
membrane (Figure 2A) (Lauber et al., 2016). Thus, from their primary sequences alone, we pre-
dicted BtuG homologs to be surface-exposed lipoproteins.
To test whether BtuG2 is indeed surface-exposed, we treated intact cells grown in minimal
medium with methionine (but without cyanocobalamin) with varying concentrations of proteinase K
(0–100 mg/mL), ran whole cell lysates on an SDS-PAGE gel, and probed by Western blot for BtuG2
or a periplasmically localized control protein SusA (BT3704) appended with a C-terminal HA-tag
(Shipman et al., 1999). While SusA was protected from protease treatment even at the highest con-
centration of protease, BtuG2 was progressively degraded at increasing concentrations of protease,
consistent with it being surface-exposed (Figure 2B). Moreover, BtuG2 associated most strongly
with the membrane of fractionated B. thetaiotaomicron cells (parent strain), and was even found in
the supernatant fraction, consistent with its localization to the interface of the outer membrane of
the cell and the extracellular milieu (Figure 2C).
Alteration of these surface-localizing sequence features diminished BtuG2 stability, complicating
efforts to directly assess the contribution of these sequences to protein localization (Figure 2—fig-
ure supplement 1A). Deleting the putative signal sequence (aa 2 – 31), mutating Cys-32 to alanine,
or changing three residues of the LES (Lys-34, Trp-35 and Asp-36) to alanine all resulted in a lack of
BtuG2 detection in whole cell lysates by Western blot, despite normal levels of transcription (Fig-
ure 2—figure supplement 1A–B). By contrast, replacing the putative signal sequence with aa 1 – 18
of the known surface-exposed lipoprotein SusD (BT1762; aa 1 – 18) (Shipman et al., 2000;
Glenwright et al., 2017), or replacing the signal sequence and LES (BtuG2 aa 1 – 37) with the signal
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 4 of 20
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sequence and LES of SusD (aa 1 – 24) complemented a btuG2 deletion strain both in terms of pro-
tein production and B12-dependent growth (Figure 2—figure supplement 1C–D). These results indi-
cate that the N-terminal residues of BtuG2 are critical for protein stability, and that these residues
can be functionally replaced with the corresponding sequences from the surface-exposed lipopro-
tein SusD.
Given that BtuG2 exhibits sequence signatures and protease sensitivity indicative of a surface-
exposed lipoprotein, is localized to the cell membrane, and contributes to B12 acquisition, we
hypothesized that it might interact with the outer membrane B12 transporter BtuB2. Consistent with
this hypothesis, we found that deletion of btuB2 changes the predominant localization of BtuG2
from the membrane fraction to the culture supernatant (Figure 2C). Furthermore, tandem affinity
purification (TAP) of BtuB2-associated proteins in growing B. thetaiotaomicron cells readily pulls
down BtuG2 (Figure 2D). By contrast, TAP of an untagged strain, or of a strain with the TAP epito-
pes appended to an unrelated TonB-dependent outer membrane b-barrel-type transporter (SusC;
BT1763) fails to pull down BtuG2. These data suggest that BtuG2 associates with known B12 trans-
port machinery.
BtuG2 directly binds cyanocobalamin with femtomolar affinity
All components of the canonical vitamin B12 transport pathway—BtuB, BtuF and BtuCD—bind cya-
nocobalamin directly during the process of transport from outside the cell into the periplasm and
ultimately the cytoplasm. To test whether BtuG2 also binds cyanocobalamin, we expressed and puri-
fied BtuG2-10xHis in E. coli. We then took advantage of the ability of cyanocobalamin to absorb
light at a wavelength of 362 nm, and aromatic amino acids within BtuG2 to absorb light at 280 nm,
by performing size-exclusion chromatography with multi-angle light scattering (SEC-MALS) on
BtuG2 after co-incubation with equimolar cyanocobalamin. At both wavelengths, we observed nearly
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Figure 2. BtuG2 is a cell surface-exposed lipoprotein that interacts with the outer membrane transporter BtuB2.
(A) N-terminus of BtuG2 and sequence logo of 114 BtuG homologs reveal sequence signatures indicative of a
surface-exposed lipoprotein, including a lipobox, adjacent cysteine residue and lipoprotein export signal (LES). (B)
Protease degradation of BtuG2 on whole B. thetaiotaomicron cells suggests BtuG2 is surface-exposed. SusA is a
periplasmic control. Data are representative of three independent trials. (C) B. thetaiotaomicron cells separated
into membrane (M), cytoplasm/periplasm (C), and supernatant (S) fractions reveal that BtuG2 is predominantly
associated with the membrane in parent cells, but predominantly associated with the supernatant in DbtuB2 cells.
Data are representative of four independent trials. (D) In vivo pull-down of BtuG2 by TAP-tagged BtuB2 suggests
an interaction with BtuB2, but not with an unrelated outer membrane b-barrel protein SusC. Data are
representative of two independent trials.
DOI: https://doi.org/10.7554/eLife.37138.005
The following figure supplement is available for figure 2:
Figure supplement 1. BtuG2 lipoprotein sequence signatures are required for protein production and can be
functionally replaced with N-terminal sequences from the unrelated cell surface lipoprotein SusD.
DOI: https://doi.org/10.7554/eLife.37138.006
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 5 of 20
Research article Microbiology and Infectious Disease
identical traces corresponding to the elution volume for BtuG2, indicating that BtuG2 can directly
bind cyanocobalamin in vitro (Figure 3A). Purified, recombinant BtuG homologs from B. vulgatus, B.
uniformis and B. coprophilus (BVU2056, BACUNI04578 and BACCOPRO02032, respectively) also
exhibit this function (Figure 3—figure supplement 1).
We then sought to determine the kinetics and affinity of cyanocobalamin binding by BtuG2.
Because BtuG2-cyanocobalamin saturation occurs too rapidly to measure the dissociation constant
accurately by isothermal titration calorimetry (data not shown), we used surface plasmon resonance
(SPR) to determine a KD of 1.87 ± 0.76  10
 13 M for BtuG2-cyanocobalamin binding and 1.93 ±
0.63  10 13 M for BtuG2-dicyanocobinamide binding (Figure 3B). Both ligands bind BtuG2 at a 1:1
ratio. BtuG2 binds to cyanocobalamin with a measured kon = 1.40 ± 0.05  10
9 M 1s 1 and a koff =
2.59 ± 0.96  10 4 s 1; similarly, BtuG2 binds to dicyanocobinamide with a measured kon = 2.61 ±
1.56  109 M 1s 1 and a koff = 4.54 ± 1.38  10
 4 s 1. Together, these measurements establish that
BtuG2 binds cyanocobalamin and a corrinoid precursor with femtomolar affinity, at a rate generally
observed for diffusion-limited enzymes and proteins. This ligand interaction is maintained for over 1
hr on average before spontaneous dissociation (Corzo, 2006). Notably, surface electrostatic analysis
of the crystal structure of BtuG2 reveals a predominantly positive electrostatic potential on the face
of BtuG2 displaying the C-terminal 6x-His tag, and a predominantly negative electrostatic potential
on the opposing face (Figure 3—figure supplement 2A). The coordinated cobalt ion of a corrinoid
carries a positive charge ranging from +1 to +3, depending in part on the upper ligand (–CN, –Me,
–Ado, –OH) (Obeid et al., 2015). Therefore, if surface electrostatic charges on BtuG2 are involved in
orienting corrinoids to facilitate protein-ligand interactions, these forces should draw the ligand into
the negative electrostatic face of BtuG2.
BtuG2 can function extracellularly as an early step in vitamin B12
acquisition and confers a fitness advantage to producer cells
Because BtuG2 modulates intracellular corrinoid levels, is surface-exposed, associates with BtuB2
and binds cyanocobalamin directly, we reasoned that it might act as a critical extracellular step in
the process of capturing and transporting corrinoids. To test whether BtuG2 can function extracellu-
larly, we measured growth of btuG2 mutant cells upon supplementation with supernatants from
btuB2 mutant cultures (this strain disproportionally partitions BtuG2 to the supernatant; Figure 2C).
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The following figure supplements are available for figure 3:
Figure supplement 1. Cyanocobalamin binding by diverse BtuG homologs.
DOI: https://doi.org/10.7554/eLife.37138.008
Figure supplement 2. Surface electrostatic profiles of the seven-bladed b-propeller proteins BtuG2,
EUBREC_1955 and MSMAS_RS11935, and the globular enzyme acetylcholinesterase.
DOI: https://doi.org/10.7554/eLife.37138.009
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To this end, we collected, filter-sterilized, ultra-centrifuged, and concentrated culture supernatants
from B. thetaiotaomicron Dlocus1 Dlocus3 DbtuB2 (or Dlocus1 Dlocus3 DbtuG2 as a control) strains
grown to exponential phase in minimal medium lacking cyanocobalamin and supplemented with
methionine. Concentrated supernatants were incubated in the presence or absence of 0.37 mM cya-
nocobalamin, diluted and concentrated repeatedly to remove unbound ligand and residual methio-
nine, and introduced to recipient cells in medium lacking both cyanocobalamin and methionine.
Under these conditions, DbtuG2 recipient cells grow robustly when provided with BtuG2-contain-
ing culture supernatant that had been incubated with cyanocobalamin (Figure 4A). By contrast, the
same recipient strain failed to grow when provided culture supernatant from a DbtuG2 strain incu-
bated with cyanocobalamin, or when provided BtuG2-containing culture supernatant incubated with
PBS instead of cyanocobalamin (Figure 4A). Further, BtuG2-containing culture supernatant incu-
bated with cyanocobalamin failed to rescue growth of recipient cells lacking corrinoid transport
machinery. These data suggest that BtuG2 can function from the exterior of cells in trans to promote
cyanocobalamin-dependent growth. Notably, BtuG2-6xHis purified from E. coli failed to restore cya-
nocoblamin-dependent growth to a DbtuG2 mutant, suggesting that lipidation or some other Bac-
teriodes-specific feature may be important for protein function (data not shown).
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Figure 4. BtuG2 can function extracellularly as a corrinoid delivery protein and confers a fitness advantage to
BtuG2 producer cells. (A) Schematic (left) and measured CFUs (right) from an experiment in which B.
thetaiotaomicron recipient cultures (DbtuG2 or Dlocus1,2,3) received donor supernatant from B. thetaiotaomicron
donor strains (DbtuB2 or DbtuG2), with or without vitamin B12. Recipient cultures were plated for CFUs over time.
Data are representative of four independent trials; *p<0.05 for black bars compared against red, yellow or blue
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and incubated at 37 ˚C anaerobically either statically (solid lines) or shaking (dotted lines). Cells were passaged
into fresh media daily and strain abundances were determined by qRT-PCR using barcode-specific primers. n.d.,
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replicates.
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The observation that BtuG2 can function in trans raises the possibility that this protein could act
as a public good, secreted into the environment and shared across cells in the population. However,
BtuG2-producing parent cells fail to rescue the cyanocobalamin-dependent growth defect of a
DbtuG2 strain when the two strains are co-cultured (Figure 4B), suggesting that this protein primar-
ily functions in cis. This is consistent with its localization as a membrane-bound lipoprotein (Figure 2)
and the competitive defect of a DbtuG2 strain in the presence of parent B. thetaiotaomicron in the
mouse gut (Figure 1E and Figure 1—figure supplement 1).
B. thetaiotaomicron can use BtuG2 to acquire cyanocobalamin from
human intrinsic factor
Because BtuG2 is surface-exposed and binds cobalamin with femtomolar affinity, we wondered if it
might affect the function of human B12-binding proteins that transport this vitamin through the
length of the gastrointestinal tract. Humans absorb cobalamin from their diet with the help of two
carrier proteins. The first, haptocorrin, is secreted from salivary glands and binds the vitamin as it is
released from food broken down in the stomach; the second, intrinsic factor (IF), is released from
parietal cells in the stomach and binds cobalamin in the duodenum following the degradation of
haptocorrin by host enzymes (Nielsen et al., 2012). IF then carries the vitamin through several
meters of intestinal tract to the distal ileum, where receptors on intestinal epithelial cells allow for
the uptake of IF and its vitamin cargo (Nielsen et al., 2012). As IF traverses the small intestinal
lumen, it encounters increasing densities of gut microbes (from ~103 to ~108 cells/g)
(Scheithauer et al., 2016).
To test whether B. thetaiotaomicron can use BtuG2 to acquire vitamin B12 from IF, we first incu-
bated recombinant human IF with cyanocobalamin, diluted and concentrated repeatedly to remove
unbound ligand, provided the IF-cyanocobalamin complexes to B. thetaiotaomicron cells in minimal
media without exogenous cyanocobalamin or methionine, and measured culture growth over time.
The parent B. thetaiotaomicron strain grew readily when provided IF-cyanocobalamin (Figure 5A).
By contrast, IF alone was not sufficient to allow bacterial growth, and recipient cells lacking btuG2
do not grow when provided IF-cyanocobalamin. Further, the parent strain is unable to grow when
provided the filtrate from the last IF-cobalamin wash step, indicating that an insignificant amount of
cobalamin dissociates from IF during dilution and concentration (Figure 5A). These results indicate
that btuG2-encoding B. thetaiotaomicron cells are capable of acquiring cyanocobalamin from IF.
To test whether BtuG2 acquires cobalamin from IF directly, we incubated cyanocobalamin with IF
and/or recombinant BtuG2 and determined the relative amounts of the vitamin associated with each
protein by SEC-MALS. As expected, incubation of BtuG2 with cyanocobalamin produces a distinct
absorbance peak at 362 nm corresponding to the elution volume for BtuG2 (Figure 5B). Similarly,
incubation of IF with cyanocobalamin produces a 362 nm absorbance peak at the elution volume
corresponding to IF. Notably, addition of BtuG2 to IF-cobalamin shifts the majority of the 362 nm
absorbance to the elution volume for BtuG2 (Figure 5B). This suggests that BtuG2 can directly
acquire cobalamin from an IF-cobalamin complex.
We next sought to determine whether this direct transfer of cobalamin from IF to BtuG2 allows B.
thetaiotaomicron to grow on cobalamin acquired from IF-cobalamin complexes. Indeed, DbtuG2
recipient cells grow readily when provided DbtuB2 culture supernatants supplemented with IF-cobal-
amin complexes (Figure 5C). The same recipient cells do not grow when provided DbtuG2 culture
supernatants supplemented with IF-cobalamin complexes, when provided DbtuB2 culture superna-
tants supplemented with IF alone, or when provided DbtuB2 culture supernatants supplemented
with the filtrate from the last wash of IF-cobalamin complexes (Figure 5C). Collectively, these results
suggest that B. thetaiotaomicron can use BtuG2 to acquire cobalamin that is already bound to the
host protein responsible for transporting this vitamin through the gastrointestinal tract.
Discussion
Early studies documenting increased vitamin requirements for germfree animals suggested that the
microbiota plays a critical role in contributing these essential cofactors to the host (Barnes, 1967). In
the case of vitamin B12, however, it is unlikely that the microbiota makes a significant contribution to
host vitamin supply. Indeed, B12 constitutes less than 2% of fecal corrinoid pools in humans, and sup-
plementation studies suggest that gut microbes efficiently convert dietary B12 into alternate
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corrinoids that cannot be used by humans (Allen and Stabler, 2008). In this report, we describe a
novel microbial factor, BtuG, that could pose a more direct obstacle to the host’s absorption of this
essential vitamin.
What evolutionary forces drove the Bacteroidetes, unlike other Gram-negative phyla, to incorpo-
rate an additional component into their B12 transport pathway that binds B12 with such high affinity?
One possible answer lies in the gut environment, where bacteria co-exist at densities of 1011 cells
per gram or higher (Whitman et al., 1998). Under these conditions, adaptations that increase corri-
noid capture could allow cells to minimize their requirement for energetically costly vitamin biosyn-
thetic pathways. Indeed, many human gut Bacteroidetes encode incomplete vitamin B12
biosynthesis pathways; B. thetaiotaomicron is missing this pathway entirely. Selection for increased
corrinoid binding affinity in BtuG could conversely permit mutations that decrease the ability of BtuB
to directly capture these molecules from the environment: E. coli, which transports B12 via BtuB and
lacks any BtuG homolog, grows readily on 0.4 nM B12 (Di Girolamo et al., 1971), while B. thetaio-
taomicron requires BtuG under these conditions (Figure 1C). An additional consequence of selection
for increased corrinoid binding affinity in BtuG is that such adaptations allow this protein to compete
with the host proteins for dietary cobalamin. In this way, the ability of BtuG to acquire B12 from IF
may have emerged as a byproduct of inter-microbial competition for gut corrinoids. Notably, BtuG
has evolved this femtomolar affinity for B12 while still maintaining the capacity to release the vitamin
for transport into the cell.
Gut bacteria can interfere with host cobalamin absorption in patients with small intestinal over-
growth of bacteria, leading to cobalamin deficiency (Giannella et al., 1971). Early efforts to find the
responsible bacteria using radiolabeled cyanocobalamin reported that Bacteroides were particularly
adept at removing cyanocobalamin from IF in vitro (Giannella et al., 1972; Schjo¨nsby et al., 1973).
Other studies describe patients with small intestinal bacterial overgrowth whose cobalamin defi-
ciency was corrected by antibiotics that target Bacteroides but not Proteobacteria (Schjo¨nsby et al.,
1977); however, the precise factors responsible for these phenomena were never defined. Our data
suggest that BtuG, which is universally present among the Bacteroides, could be one extracellular
factor responsible for these observations. Although BtuG-mediated vitamin piracy may be well toler-
ated by a healthy host, conditions of small intestinal bacterial overgrowth or diminished IF produc-
tion could alter this effect. Notably, even minor B12 deficiencies (historically assigned to the
‘subclinical’ range) could have health consequences (McCaddon, 2013; Moore et al., 2012).
A comparison of measured binding kinetics of BtuG2 and IF may explain how this bacterial pro-
tein extracts cobalamin from IF, which also binds the vitamin very strongly. Reported equilibrium dis-
sociation constants for IF and cobalamin span a broad range (KD ~10
 9–10 15 M); the most extreme
of these describes a KD ~5  10
 15 M, a kon ~7  10
7 M 1s 1 and a koff ~4  10
 7 s 1
(Fedosov et al., 2005; Brada et al., 2001; Fedosov et al., 2006). By comparison, BtuG2 has a
KD ~2  10
 13 M, a kon ~1  10
9 M 1s 1 and a koff ~3  10
 4 s 1 (Figure 3B). This kon rate, which is
similar to that previously measured in diffusion-limited enzymes and proteins (Corzo, 2006), is
orders of magnitude greater than the kon for IF. This suggests that BtuG2 has a superior ability to
bind up free cobalamin compared with IF.
The different environments in which these proteins encounter free cobalamin could explain these
differences in kon rates. In humans, IF first encounters free cobalamin in the duodenum, where the
vitamin is released from haptocorrin by host enzymes. At this juncture, there are few gut microbes
present (~103 per gram) to compete with IF for free cobalamin (Scheithauer et al., 2016). By con-
trast, microbial densities in the large intestine exceed 1011 per gram, thus introducing a stronger ele-
ment of competition for free corrinoids among gut microbes (Whitman et al., 1998). Therefore,
Figure 5 continued
of recombinant human IF and/or recombinant BtuG2 incubated with vitamin B12. 362 nm absorbance measures B12-associated proteins and each trace
represents one of the four conditions illustrated in the schematic. Data are representative of two independent trials. (C) Schematic (left) and CFUs (right)
from an experiment in which B. thetaiotaomicron recipient cultures (DbtuG2) received recombinant human IF with or without vitamin B12 or the filtrate
from the last IF–B12 wash, and donor supernatant from B. thetaiotaomicron strains (DbtuB2 or DbtuG2). Recipient cultures were plated for CFUs over
time. Data are representative of two independent trials; *p<0.05 for black bars compared against red, yellow or blue bars; error bars indicate ± SD from
two biological replicates.
DOI: https://doi.org/10.7554/eLife.37138.011
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BtuG2 may face a stronger selective pressure to augment its kon rate in order to remain competitive
against other BtuG homologs in the microbiota.
The koff rate of IF is orders of magnitude lower than the koff rate of BtuG2, corresponding to an
average protein–ligand association time of ~700 hr for IF–cobalamin versus ~1 hr for BtuG2–cobala-
min. Although both of these proteins bind B12 for delivery to their respective receptor, their different
tasks may explain the observed koff rates. IF binds cobalamin in the proximal small intestine (duode-
num), but its uptake receptors on epithelial cells are located exclusively in the distal small intestine
(ileum). Therefore, IF must maintain its association with cobalamin while traversing several meters of
intestinal tract before the host can absorb its nutrient cargo. By contrast, BtuG2 localizes to the bac-
terial cell surface and likely acts in cis to capture extracellular corrinoids for subsequent delivery to
the outer membrane receptor BtuB on the same cell. This difference in protein function may impose
differences in selective pressure for koff rates.
Although BtuG2 and IF thus achieve these strong binding affinities by different kinetics, mixing
the proteins results in a transfer of cobalamin from IF to BtuG2 (Figure 5). It is unclear whether this
occurs through a direct interaction between BtuG2 and IF. Diffusion-limited enzymes and proteins
(e.g., acetylcholinesterase and superoxide dismutase) can employ surface electrostatic charges to
affect the fluid environment in their immediate vicinity in ways that can enhance the likelihood of
protein–ligand contact beyond the frequency determined through diffusion alone (Tan et al., 1993;
Getzoff et al., 1983). Acetylcholinesterase, for example, exhibits contrasting electrostatic charge
distributions on opposing faces of the enzyme, creating an electrostatic dipole that is reported to
drive the interaction between the enzyme and its positively charged ligand (Figure 3—figure sup-
plement 2A) (Ripoll et al., 1993; Tan et al., 1993). BtuG2 also presents one face with a predomi-
nantly positive electrostatic potential and the other with a strikingly negative electrostatic potential
(Figure 3—figure supplement 2A-B). While the b-propeller structure of BtuG2, which resembles a
disk with a central hole, may contribute to the formation of a dipolar electrostatic field through the
middle of the protein, these properties are not intrinsic to seven-bladed b-propeller proteins (Fig-
ure 3—figure supplement 2A-B). Because the coordinated cobalt ion of corrinoids carries a positive
charge, surface electrostatic charges could be involved in orienting free corrinoids to facilitate pro-
tein–ligand interactions by repelling corrinoids away from the positive electrostatic face while draw-
ing them into the negative electrostatic face of BtuG2. This uncommon surface electrostatic charge
distribution in BtuG2 could potentially alter IF–cobalamin stability without direct interaction between
the two proteins.
Although our evidence of BtuG lipidation is indirect, the use of cell surface-level machinery to
enhance the uptake of key nutrients is not unprecedented for gut microbes. For example, the Bac-
teroides each encode dozens of Sus-like systems, defined by the presence of an outer membrane b-
barrel protein (e.g. SusC), a cell surface-exposed lipoprotein (e.g., SusD), and other components
that directly interact to digest and import various polysaccharides into the cell (Koropatkin et al.,
2012; Glenwright et al., 2017). Our studies suggest that surface-exposed nutrient binding proteins
may determine the ability of these bacteria to not only capture carbon, but also to drive the ‘second-
ary economy’ of critical vitamins that power microbial growth in the gut.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background (E. coli)
S17-1 lambda pir PMID_6340113 thi pro hdsR
hdsM + recA,
chromosomal
insertion of
RP4-2(Tc::Mu Km::Tn7),
AmpS
Strain, strain
background (E. coli)
BL21 Rosetta (DE3) Novagen F- ompT hsdSB(rB
- mB
-)
gal dcm (DE3)
pRARE (CamR)
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Strain, strain
background
(Bacteroides
thetaiotaomicron)
VPI-5482 Dtdk PMID_18611383
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk
Dlocus1 Dlocus3
PMID_24439897
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
DbtuG2 Dlocus3
This paper
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
DbtuB2 Dlocus3
PMID_24439897
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
Dlocus2 Dlocus3
PMID_24439897
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk
Dlocus1 Dlocus3 att::
pNBU2_tet_BC01
This paper
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
DbtuG2 Dlocus3 att::
pNBU2_tet_BC14
This paper
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
DbtuB2 Dlocus3 att::
pNBU2_tet_BC14
This paper
Strain, strain
background
(B. thetaiotaomicron)
VPI-5482 Dtdk Dlocus1
DbtuG2 Dlocus3 att::pNBU2_tet_BC16
_us1957_btuG2
This paper
Strain, strain
background (E. coli)
BL21 Rosetta (DE3)
pET21_NESG_btuG2
This paper
Strain, strain
background (E. coli)
BL21 Rosetta
(DE3) pET21_NESG_
btuG2_10xHis
This paper
Strain, strain
background (E. coli)
BL21 Rosetta
(DE3) pET21_NESG
_BVU2056
This paper
Strain, strain
background (E. coli)
BL21 Rosetta
(DE3) pET21_NESG_
BACUNI04578
This paper
Strain, strain
background (E. coli)
BL21 Rosetta
(DE3) pET21_NESG_
BACCOPRO02032
This paper
Recombinant
DNA reagent
pExchange-tdk PMID: 18611383 plasmid
Recombinant
DNA reagent
pExchange_tdk_DbtuG2 plasmid
Recombinant
DNA reagent
pNBU2_ermG PMID: 18611383 plasmid
Recombinant
DNA reagent
pNBU2_ermG_us1957 This paper plasmid
Recombinant
DNA reagent
pNBU2_tet_BC01 PMID: 18996345 plasmid
Recombinant
DNA reagent
pNBU2_tet_BC14 PMID: 18996345 plasmid
Recombinant
DNA reagent
pNBU2_tet_BC16 PMID: 24439897 plasmid
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers
Additional
information
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuG2_C32A
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuG2_Dss
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuG2_K34A W35A D36A
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuG2_susD-ss
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuG2_susD-ss-LES
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_btuB2_FLAG_HA
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_BT1763_FLAG_HA
This paper plasmid
Recombinant
DNA reagent
pNBU2_erm_us1957
_BT3704_HA
This paper plasmid
Recombinant
DNA reagent
pET21_NESG_btuG2 Northeast
Structural Genomics
Consortium; PDB 3DSM
plasmid
Recombinant
DNA reagent
pET21_NESG_btuG2
_10xHis
This paper plasmid
Recombinant
DNA reagent
pET21_NESG_
BVU2056
This paper plasmid
Recombinant
DNA reagent
pET21_NESG_
BACUNI04578
This paper plasmid
Recombinant
DNA reagent
pET21_NESG_
BACCOPRO02032
This paper plasmid
Bacterial culture conditions
Culturing of Bacteroides thetaiotaomicron VPI-5482 was carried out in an anaerobic chamber (Coy
Laboratory Products, Grass Lake, MI, USA), filled with 70% N2, 20% CO2, and 10% H2 by volume,
using minimal media with vitamin B12 omitted (Martens et al., 2008) supplemented where specified
with 500 mM DL-methionine and/or vitamin B12 (0, 0.37 or 37 nM). Escherichia coli S17-1 lambda pir
or BL21 Rosetta (DE3) strains were grown in LB medium and incubated aerobically at 37˚C. Culture
media were supplemented with antibiotics as needed at the following concentrations: ampicillin 100
mg/mL, chloramphenicol 30 mg/mL, erythromycin 25 mg/mL, gentamicin 200 mg/mL, tetracycline 2
mg/mL, and 5-fluoro-20-deoxyuridine (FUdR) 200 mg/mL.
Genetic techniques
Plasmid constructs (Supplementary file 1) were created, maintained and transformed using stan-
dard molecular cloning procedures. Primers (Supplementary file 1) were obtained from the Keck
Biotechnology Resource Laboratory (Yale University, New Haven, CT, USA) and DNA amplification
was performed using KAPA HiFi ReadyMix (Kapa Biosystems, Wilmington, MA, USA). Gene deletions
in B. thetaiotaomicron were carried out as previously reported using B. thetaiotaomicron Dtdk
Dlocus1 Dlocus3 as a parent strain (Degnan et al., 2014a) by amplifying flanking regions (~1000 bp)
of genes of interest and joining them by splicing by overlap extension (SOE) PCR or Gibson assem-
bly. The concatenated fragments were inserted into the suicide vector pExchange-tdk
(Martens et al., 2008) via ligation or Gibson assembly. Clones were sequence-verified and intro-
duced into B. thetaiotaomicron Dtdk Dlocus1 Dlocus3 by conjugation. Following counter selection,
gene deletions were confirmed by PCR. Gene complementation constructs were created using
pNBU2 vectors (with or without oligonucleotide barcodes) introduced in single copy into B. thetaio-
taomicron as previously described (Martens et al., 2008). Complementation constructs contained
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425 bp upstream of BT1957, the first gene in locus2, to capture the locus2 promoter and vitamin B12
riboswitch (us1957, Supplementary file 1).
Comparative genomics and computational analyses
Identification of BtuG homologs
BlastP searches were carried out with BT1490, BT1954 and BT2095 as queries against the predicted
proteomes of 313 human gut bacteria (Degnan et al., 2014a) and e-value cutoff of 1e-10. Results
were collated, de-replicated and BtuG homologs assigned to btuB-containing operons described
previously (Degnan et al., 2014a). btuB-containing operons without a btuG homolog and btuG-con-
taining operons without a previously characterized btuB gene were manually inspected using BlastP
and Phyre2 (Altschul et al., 1990; Kelley and Sternberg, 2009).
BtuG sequence logo
The first 90 amino acids of 114 BtuG homologs (Supplementary file 1) were aligned in ClustalW
(Larkin et al., 2007). Their sequence conservation was displayed via sequence logo (Crooks et al.,
2004; Schneider and Stephens, 1990).
BtuG gene tree
A multiple sequence alignment of 114 homologs of BtuG2 (Supplementary file 1) was generated in
MAFFT (Katoh et al., 2002) and converted into a gene tree using FigTree.
Protein surface electrostatic analysis
PDB 3DSM, 3S25, 1L0Q and 1GQR were converted to PQR files using the PDB2PQR server under
default settings (Dolinsky et al., 2004). The resulting surface electrostatic profiles were then ana-
lyzed and viewed using an adaptive Poisson-Boltzmann solver (APBS) in PyMOL.
Protein structure overlay
The crystal structures of BtuG2 (PDB 3DSM) and the N-terminal domain of the M. mazei S-layer pro-
tein MSMAS_RS11935 (PDB 1L0Q, Chain A; Jing et al., 2002) were aligned by super-positioning of
the C-alpha backbones using the TOPP program in the CCP4 protein crystallography suite
(Lu, 1996), Collaborative Computational Project Number 4, 1994). Images were prepared using Chi-
mera (Pettersen et al., 2004).
Growth curves
Overnight cultures of B. thetaiotaomicron strains grown in minimal medium supplemented with
methionine (no B12) were pelleted, washed three times in minimal medium without methionine or
vitamin B12, and used to inoculate wells of a 96-well plate in triplicate containing minimal media with
methionine or vitamin B12 (0, 0.37 or 37 nM). The plate was incubated anaerobically under constant
agitation for 72 hr at 37˚C and OD600 measurements were taken at regular intervals using a BioTek
Eon microplate spectrophotometer.
In vitro bacterial competitions
B. thetaiotaomicron strains carrying unique oligonucleotide barcodes were co-cultured in minimal
media in triplicate as previously described (Degnan et al., 2014a; Martens et al., 2008). Briefly, B.
thetaiotaomicron strains were grown overnight in minimal media supplemented with methionine,
washed and resuspended in minimal media without methionine or vitamin B12. OD600 was measured
and used to create a 1:10 mixture of competing strains (1 part parent strain to 10 parts DbtuG2
strain), which was then used to inoculate, at 1:1000, minimal media supplemented with methionine
or vitamin B12 (0, 0.37, or 37 nM). These inoculations were then incubated anaerobically at 37 ˚C
under static conditions or shaking (250 rpm). Cultures were passaged at 1:1000 into fresh media
every 24 hr and an aliquot was stored at  20 ˚C for gDNA extraction (Truett et al., 2000). Relative
strain abundances were determined by quantitative PCR (qPCR) using a CFX96 thermocycler (Bio-
Rad, Hercules, CA, USA) and SYBR FAST Universal Mastermix (KAPA Biosystems, Wilmington, MA,
USA) (Degnan et al., 2014a). Strain abundances were analyzed using a standard curve and effi-
ciency-corrected DCq method was used to determine relative fold changes (Bookout et al., 2006).
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Gnotobiotic animal studies
All animal experiments were performed using protocols approved by the Yale University Institutional
Animal Care and Use Committee. Male and female germfree 8- to 12-week-old Swiss Webster mice
were individually caged and maintained in flexible plastic gnotobiotic isolators with a 12 hr light/
dark cycle. Mice were provided with standard autoclaved mouse chow (5K67 LabDiet; Purina, St.
Louis, MO, USA) ad libitum. Germfree mice were colonized with 200 mL bacterial glycerol stocks by
oral gavage. Mice were divided into groups (n = 4 – 5/group). Each mouse in the first group was
gavaged with 108 CFU each of B. thetaiotaomicron Dtdk Dlocus1 Dlocus3 att1::pNBU2_tetQ_BC01
(‘parent’ strain) and B. thetaiotaomicron Dtdk Dlocus1 Dlocus3 DbtuG2 att1::pNBU2_tetQ_BC14
(‘DbtuG2’ strain). Each mouse in the second group was gavaged with 108 CFU each of the parent
strain and B. thetaiotaomicron Dtdk Dlocus1 Dlocus3 DbtuB2 att1::pNBU2_tetQ_BC14 (‘DbtuB2’
strain). Each mouse in the third group was gavaged with ~107 CFU each of the parent strain, the
DbtuG2 strain, and B. thetaiotaomicron Dtdk Dlocus1 Dlocus3 DbtuG2 att1::pNBU2_tetQ_B-
C16_us1957_btuG2 (‘DbtuG2 + btuG2’ strain). Fecal samples were collected over time and stored at
 80˚C before genomic DNA extraction. DNA was extracted as described previously (Cullen et al.,
2015). The relative abundance of each strain was determined using oligonucleotide barcode-specific
primers (Supplementaryfile 1) in a qPCR assay as described above.
B12 riboswitch biosensor assays
B. thetaiotaomicron strains were grown in triplicate anaerobically at 37 ˚C to mid-log phase
(OD600 ~0.3) in minimal media supplemented with methionine and vitamin B12 (0, 0.37, or 37 nM).
RNA was extracted using a cell lysis buffer (10 mM Tris pH 8.0, 1 mM EDTA, 0.2 mg lysozyme, 0.5
mg proteinase K) and an RNeasy kit (Qiagen, Hilden, Germany). DNA was removed using DNA-free
DNA Removal Kit (Invitrogen, Carlsbad, CA, USA), and RNA was again cleaned using an RNeasy kit
(Qiagen, Hilden, Germany). cDNA was then made with SuperScript II Reverse Transcriptase (Invitro-
gen, Carlsbad, CA, USA) using the manufacturer’s instructions, and RNA was removed with 1 N
NaOH at 65 ˚C for 30 min and neutralized with 1 N HCl. Samples were then cleaned using a PCR
purification kit (Qiagen) and cDNA was quantified using a Qubit (Invitrogen, Carlsbad, CA, USA).
Quantitative PCR was performed using SYBR FAST Universal Mastermix (KAPA Biosystems, Wilming-
ton, MA, USA) and gene-specific primers (Supplementary file 1). Samples were normalized first to
16S rRNA expression for each individual sample and replicate, and then normalized to the expres-
sion level of each strain in 0 nM B12 (Figure 1D) or the btuG2 complement strain in 0.37 nM B12 (Fig-
ure 2—figure supplement 1B). A standard curve and efficiency-corrected DCq method was used to
determine relative fold changes (Bookout et al., 2006).
Immunoblotting
Detection of BtuG2 from B. thetaiotaomicron lysates was performed by Western blot analysis using
a custom-made rabbit anti-BtuG2 polyclonal antibody (Cocalico Biologicals, Reamstown, PA, USA).
Proteinase K assay
A B. thetaiotaomicron strain expressing an HA-epitope tagged allele of the periplasmic protein
SusA (Shipman et al., 1999) was grown to OD600 ~0.8 in minimal media with methionine, pelleted
and washed in 1x cOmplete EDTA-free protease-inhibitor cocktail (Roche, Basel, Switzerland) before
being pelleted and stored at  80 ˚C. Pellets were thawed and resuspended in PBS with proteinase K
(0, 10, 50 or 100 mg/mL; AmericanBio, Natick, MA, USA), and incubated at 37 ˚C aerobically under
continuous agitation (250 rpm) for 8 hr. Cells were then pelleted and washed 3 times in 1x cOmplete
EDTA-free protease-inhibitor cocktail, pelleted and stored at  80 ˚C. Thawed cells were lysed using
BugBuster reagent (Millipore Sigma, Burlington, MA, USA), 20 mg of clarified protein lysate was
loaded onto an SDS-PAGE gel, transferred to a PVDF membrane and probed with rabbit anti-BtuG2
and rabbit anti-HA (Santa Cruz Biotechnology, Dallas, TX, USA).
Cell fractionation
B. thetaiotaomicron cultures were grown to OD600 ~0.6 in minimal media with methionine. Cells
were pelleted (~3000 x g for 15 min at 4˚C) and supernatant was filtered through 0.2 mm filter and
stored temporarily on ice. Pellets were resuspended in breakage buffer (50 mM Tris pH 8, 5 mM
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EDTA, 2 mM PMSF, 10% glycerol), lysed at 4˚C by sonication (40 Amps; 15 s ‘on’ and 30 s ‘off’; 3
min total), and clarified lysates were ultracentrifuged at 100,000 x g for 1 hr at 4˚C to separate mem-
branes (insoluble) from cytoplasm/periplasm (soluble) fractions. Membrane fractions were resus-
pended in 250 ml of breakage buffer, while the cytoplasm/periplasm fraction was concentrated by
centrifugal filtration (30K; Millipore Sigma, Burlington, MA, USA) to 250 ml. Membrane and cyto-
plasm/periplasm fractions were temporarily stored on ice. Filtered supernatant was utracentrifuged
at ~100,000 x g for 1 hr at 4˚C to remove outer membrane vesicles. The soluble fraction was then
concentrated by centrifugal filtration to 250 ml. 20 ml each of membrane, cytoplasm/periplasm, and
supernatant fractions were loaded onto SDS-PAGE gels and analyzed by Western blot. PVDF mem-
branes were probed with rabbit anti-BtuG2 and mouse anti-RpoB (Santa Cruz Biotechnology, Dallas,
TX, USA) as a cytoplasmic control.
Co-immunoprecipitation
B. thetaiotaomicron strains were grown to OD600 ~0.6 in minimal media with methionine. Cells
were pelleted, supernatant was removed, and cells were lysed with BugBuster reagent. Co-immuno-
precipitation was carried out using FLAG HA Tandem Affinity Purification kit (Millipore Sigma, Bur-
lington, MA, USA) according to the manufacturer’s instructions. Eluates were probed with rabbit
anti-BtuG2 by Western blot.
Trans-complementation assays
Overnight cultures of B. thetaiotaomicron strains were grown in minimal media with methionine.
Supernatant donor strains were subcultured (1:100) into 60 mL fresh minimal media with methionine
and allowed to grow to OD600 ~0.6. Supernatant recipient strains were washed 3 times in minimal
media without methionine or vitamin B12, subcultured to a final OD600 ~0.001 in 1 mL minimal
media without methionine or vitamin B12, and incubated at 37 ˚C anaerobically for 8 – 12 hr. Super-
natant donor cultures were pelleted and supernatant filtered (0.2 mm). Filtered supernatants were
then ultracentrifuged at 100,000 x g for 1 hr at 4 ˚C to remove outer membrane vesicles and concen-
trated to <2 mL by centrifugal filtration (30K; Millipore Sigma, Burlington, MA, USA). Where indi-
cated, concentrated supernatants were supplemented with 0.37 mM vitamin B12 or PBS and
incubated for 20 min at room temperature aerobically on a nutator. Supernatants were then washed
4 times in 70 mL minimal media without methionine or vitamin B12 by centrifugal filtration (30K).
Washed, concentrated supernatants were then applied to recipient cell cultures and incubated at 37
˚C anaerobically. CFU measurements were taken at regular intervals. For assays involving IF, recom-
binant human IF (Xeragenx LLC) was incubated in 0.37 mM vitamin B12 or PBS for 20 min at room
temperature on a nutator, and washed 4 times in 70 mL minimal media without methionine or vita-
min B12 via centrifugal filtration (30K). IF (± vitamin B12) was provided either alone to recipient cell
cultures (e.g., Figure 5A) or with B12-free donor supernatants (e.g., Figure 5C) at a final concentra-
tion of 10 nM IF per replicate. Cultures were incubated at 37˚C anaerobically and CFU measure-
ments were taken at regular intervals.
Size-exclusion chromatography with multi-angle light scattering (SEC-
MALS)
Recombinant BtuG2-6xHis or BtuG2-10xHis was expressed and purified from E. coli BL21 Rosetta
(DE3) carrying a modified pET21 vector. Cells were grown to OD600 ~0.6 before being induced for
3 hr in 0.5 mM IPTG at 37 ˚C under constant agitation. Cell pellets were lysed using BugBuster
reagent (Millipore Sigma, Burlington, MA, USA). Lysates were incubated for 1 hr at 4 ˚C with Ni-NTA
agarose beads (Qiagen, Hilden, Germany) and washed with 12 – 18 mL of wash buffer (50 mM
NaH2PO4, 300 mM NaCl, 20 mM imidazole pH 7.4), and eluted with 6 mL elution buffer (50 mM
NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 7.4). BtuG2-6xHis or BtuG2-10xHis fractions were
dialyzed overnight in 20 mM Tris pH eight before being spun through a PierceTM strong anion
exchange column (ThermoFisher Scientific, Waltham, MA, USA) according to the manufacturer’s
instructions. Eluted proteins were dialyzed twice for 4–8 hr in 4 L of PBS, pH 8. Proteins were quanti-
fied by Bradford assay (Bio-Rad, Hercules, CA, USA) according to the manufacturer’s instructions.
BtuG2-6xHis was incubated at a 1:1 molar ratio of cyanocobalamin to protein for 30 min at 25 ˚C
and analyzed by SEC-MALS. BtuG2-10xHis was enriched for protein monomers by size exclusion
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chromatography and quantified using a NanoDrop spectrophotometer (ThermoFisher Scientific,
Waltham, MA, USA) for use in SPR experiments (described below).
Cyanocobalamin binding by BtuG homologs from B. thetaiotaomicron,
B. vulgatus, B. uniformis and B. coprophilus
pET21_NESG was used to express and purify C-terminal 6xHis-tagged versions of the BtuG homo-
logs BVU2056, BACUNI04578 and BACCOPRO02032 as described above for BtuG2. Each BtuG
homolog, or BSA or PBS as controls, was incubated at a 1:1 molar ratio of cyanocobalamin to pro-
tein for 30 min at 25 ˚C before being spun through a centrifugal filter (30K; Millipore Sigma, Burling-
ton, MA, USA) to elute unbound cyanocobalamin. Proteins were washed 3 times with 400 ml PBS.
Retained protein-cyanocobalamin complexes were resuspended in 100 ml PBS and analyzed by spec-
trophotometry for absorbance at 360 nm, corresponding to cyanocobalamin.
Surface plasmon resonance (SPR)
Binding studies were performed at 25˚C using a Biacore T100 optical biosensor (GE HealthCare, Bia-
core, Piscataway, NJ, USA). Recombinant BtuG2-10xHis was purified from E. coli BL21 Rosetta (DE3)
as described above and immobilized on a NTA chip. Cyanocobalamin was injected at 0.8, 0.4, 0.2,
0.1, and 0.05 nM and the binding was monitored in single cycle kinetics in PBS (Karlsson et al.,
2006). Binding responses were double-referenced against non-specific binding to dextran and the
NTA surface alone, and against injections of buffer alone. Binding affinity was determined by fitting
the kinetics of the binding reaction to a 1:1 binding model using BioEvaluation software (GE Health-
Care, Biacore, Piscataway, NJ, USA).
Acknowledgements
We thank members of ALG’s laboratory; Michiko Taga, Kenny Mok, and Nicole Koropatkin for help-
ful discussions; the Northeast Structural Genomics Consortium for pET21_NESG_BT1954; Robert
Doyle and Xeragenx LLC for the gift of recombinant human intrinsic factor. This work was supported
by NIH grants GM118159, GM103574, the Burroughs Wellcome Fund, and the Howard Hughes
Medical Institute Faculty Scholars Program to ALG, and support from the Gruber Science Fellowship
Program to AGW.
Additional information
Funding
Funder Grant reference number Author
National Institutes of Health GM118159 Andrew L Goodman
Burroughs Wellcome Fund 1014860 Andrew L Goodman
Howard Hughes Medical Insti-
tute
55108526 Andrew L Goodman
Gruber Foundation Graduate Student
Fellowship
Aaron G Wexler
National Institutes of Health GM103574 Andrew L Goodman
The funders had no role in study design, data collection and interpretation, or the
decision to submit the work for publication.
Author contributions
Aaron G Wexler, Data curation, Formal analysis, Investigation, Visualization, Methodology, Writing—
original draft; Whitman B Schofield, Investigation, Writing—review and editing; Patrick H Degnan,
Formal analysis, Investigation, Methodology, Writing—review and editing; Ewa Folta-Stogniew, For-
mal analysis, Methodology; Natasha A Barry, Investigation, Methodology; Andrew L Goodman, Con-
ceptualization, Resources, Formal analysis, Supervision, Funding acquisition, Writing—original draft,
Writing—review and editing
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 17 of 20
Research article Microbiology and Infectious Disease
Author ORCIDs
Aaron G Wexler http://orcid.org/0000-0001-7926-089X
Andrew L Goodman http://orcid.org/0000-0001-7599-3471
Ethics
Animal experimentation: This study was performed in strict accordance with the recommendations
in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. All of
the animals were handled according to approved institutional animal care and use committee
(IACUC) protocols (#2017-11423) of Yale University.
Decision letter and Author response
Decision letter https://doi.org/10.7554/eLife.37138.015
Author response https://doi.org/10.7554/eLife.37138.016
Additional files
Supplementary files
. Supplementary file 1. (Table S1) Identified BtuB-BtuG pairs from BlastP and Phyre2 searches of
BT1490, BT1954 and BT2095. (Table S2) Amino acid sequences of 114 BtuG homologs used to cre-
ate the sequence logo in Figure 2A. (Table S3) Bacterial strains, plasmids and oligonucleotide pri-
mers used in this study.
DOI: https://doi.org/10.7554/eLife.37138.012
. Transparent reporting form
DOI: https://doi.org/10.7554/eLife.37138.013
All data generated or analyzed during this study are included in the manuscript and supporting files.
Source data files have been provided for Figures 1A and 2A.
References
Allen RH, Stabler SP. 2008. Identification and quantitation of cobalamin and cobalamin analogues in human
feces. The American Journal of Clinical Nutrition 87:1324–1335. DOI: https://doi.org/10.1093/ajcn/87.5.1324,
PMID: 18469256
Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. 1990. Basic local alignment search tool. Journal of
Molecular Biology 215:403–410. DOI: https://doi.org/10.1016/S0022-2836(05)80360-2, PMID: 2231712
Arenas FA, Dı´az WA, Leal CA, Pe´rez-Donoso JM, Imlay JA, Va´squez CC. 2010. The Escherichia coli btuE gene,
encodes a glutathione peroxidase that is induced under oxidative stress conditions. Biochemical and
Biophysical Research Communications 398:690–694. DOI: https://doi.org/10.1016/j.bbrc.2010.07.002,
PMID: 20621065
Barnes RH. 1967. Contributions of the intestinal microflora to the nutrition of the host. Vitamins & Hormones 24:
115–171.
Bassford PJ, Bradbeer C, Kadner RJ, Schnaitman CA. 1976. Transport of vitamin B12 in tonB mutants of
Escherichia coli. Journal of Bacteriology 128:242–247. PMID: 135755
Bassford PJ, Kadner RJ. 1977. Genetic analysis of components involved in vitamin B12 uptake in Escherichia coli.
Journal of Bacteriology 132:796–805. PMID: 336607
Bookout AL, Cummins CL, Mangelsdorf DJ, Pesola JM, Kramer MF. 2006. High-Throughput Real-Time
quantitative reverse transcription PCR. Current Protocols in Molecular Biology 73:15.8.1–15.815. DOI: https://
doi.org/10.1002/0471142727.mb1508s73
Brada N, Gordon MM, Wen J, Alpers DH. 2001. Transfer of cobalamin from intrinsic factor to transcobalamin II.
The Journal of Nutritional Biochemistry 12:200–206. DOI: https://doi.org/10.1016/S0955-2863(00)00129-7,
PMID: 11287214
Cadieux N, Bradbeer C, Reeger-Schneider E, Ko¨ster W, Mohanty AK, Wiener MC, Kadner RJ. 2002. Identification
of the periplasmic cobalamin-binding protein BtuF of Escherichia coli. Journal of Bacteriology 184:706–717.
DOI: https://doi.org/10.1128/JB.184.3.706-717.2002, PMID: 11790740
Collaborative Computational Project, Number 4. 1994. The CCP4 suite: programs for protein crystallography.
Acta Crystallographica Section D Biological Crystallography 50:760–763. DOI: https://doi.org/10.1107/
S0907444994003112, PMID: 15299374
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 18 of 20
Research article Microbiology and Infectious Disease
Corzo J. 2006. Time, the forgotten dimension of ligand binding teaching. Biochemistry and Molecular Biology
Education 34:413–416. DOI: https://doi.org/10.1002/bmb.2006.494034062678, PMID: 21638733
Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Research
14:1188–1190. DOI: https://doi.org/10.1101/gr.849004, PMID: 15173120
Cullen TW, Schofield WB, Barry NA, Putnam EE, Rundell EA, Trent MS, Degnan PH, Booth CJ, Yu H, Goodman
AL. 2015. Antimicrobial peptide resistance mediates resilience of prominent gut commensals during
inflammation. Science 347:170–175. DOI: https://doi.org/10.1126/science.1260580, PMID: 25574022
de Veaux LC, Clevenson DS, Bradbeer C, Kadner RJ. 1986. Identification of the btuCED polypeptides and
evidence for their role in vitamin B12 transport in Escherichia coli. Journal of Bacteriology 167:920–927.
DOI: https://doi.org/10.1128/jb.167.3.920-927.1986, PMID: 3528128
Degnan PH, Barry NA, Mok KC, Taga ME, Goodman AL. 2014a. Human gut microbes use multiple transporters
to distinguish vitamin B12 analogs and compete in the gut. Cell Host & Microbe 15:47–57. DOI: https://doi.org/
10.1016/j.chom.2013.12.007, PMID: 24439897
Degnan PH, Taga ME, Goodman AL. 2014b. Vitamin B12 as a modulator of gut microbial ecology. Cell
Metabolism 20:769–778. DOI: https://doi.org/10.1016/j.cmet.2014.10.002, PMID: 25440056
Di Girolamo PM, Kadner RJ, Bradbeer C. 1971. Isolation of vitamin B 12 transport mutants of Escherichia coli.
Journal of Bacteriology 106:751–757. PMID: 4326741
Dolinsky TJ, Nielsen JE, McCammon JA, Baker NA. 2004. PDB2PQR: an automated pipeline for the setup of
Poisson-Boltzmann electrostatics calculations. Nucleic Acids Research 32:W665–W667. DOI: https://doi.org/10.
1093/nar/gkh381, PMID: 15215472
Fedosov SN, Fedosova NU, Berglund L, Moestrup SK, Nexø E, Petersen TE. 2005. Composite organization of
the cobalamin binding and cubilin recognition sites of intrinsic factor. Biochemistry 44:3604–3614. DOI: https://
doi.org/10.1021/bi047936v, PMID: 15736970
Fedosov SN, Grissom CB, Fedosova NU, Moestrup SK, Nexø E, Petersen TE. 2006. Application of a fluorescent
cobalamin analogue for analysis of the binding kinetics. A study employing recombinant human transcobalamin
and intrinsic factor. The FEBS journal 273:4742–4753. DOI: https://doi.org/10.1111/j.1742-4658.2006.05478.x,
PMID: 16984395
Fowler CC, Brown ED, Li Y. 2010. Using a riboswitch sensor to examine coenzyme B(12) metabolism and
transport in E. coli. Chemistry & Biology 17:756–765. DOI: https://doi.org/10.1016/j.chembiol.2010.05.025,
PMID: 20659688
Getzoff ED, Tainer JA, Weiner PK, Kollman PA, Richardson JS, Richardson DC. 1983. Electrostatic recognition
between superoxide and copper, zinc superoxide dismutase. Nature 306:287–290. DOI: https://doi.org/10.
1038/306287a0, PMID: 6646211
Giannella RA, Broitman SA, Zamcheck N. 1971. Vitamin B12 uptake by intestinal microorganisms: mechanism
and relevance to syndromes of intestinal bacterial overgrowth. Journal of Clinical Investigation 50:1100–1107.
DOI: https://doi.org/10.1172/JCI106581, PMID: 4994753
Giannella RA, Broitman SA, Zamcheck N. 1972. Competition between bacteria and intrinsic factor for vitamin B
12 : implications for vitamin B 12 malabsorption in intestinal bacterial overgrowth. Gastroenterology 62:255–
260. PMID: 4629318
Glenwright AJ, Pothula KR, Bhamidimarri SP, Chorev DS, Basle´ A, Firbank SJ, Zheng H, Robinson CV,
Winterhalter M, Kleinekatho¨fer U, Bolam DN, van den Berg B, David N, Berg Bvanden. 2017. Structural basis
for nutrient acquisition by dominant members of the human gut microbiota. Nature 541:407–411. DOI: https://
doi.org/10.1038/nature20828, PMID: 28077872
Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, Lozupone CA, Knight R, Gordon JI. 2009. Identifying
genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host & Microbe 6:279–289.
DOI: https://doi.org/10.1016/j.chom.2009.08.003, PMID: 19748469
Inouye S, Franceschini T, Sato M, Itakura K, Inouye M. 1983. Prolipoprotein signal peptidase of Escherichia coli
requires a cysteine residue at the cleavage site. The EMBO Journal 2:87–91. PMID: 11894915
Jing H, Takagi J, Liu JH, Lindgren S, Zhang RG, Joachimiak A, Wang JH, Springer TA. 2002. Archaeal surface
layer proteins contain beta propeller, PKD, and beta helix domains and are related to metazoan cell surface
proteins. Structure 10:1453–1464. DOI: https://doi.org/10.1016/S0969-2126(02)00840-7, PMID: 12377130
Karlsson R, Katsamba PS, Nordin H, Pol E, Myszka DG. 2006. Analyzing a kinetic titration series using affinity
biosensors. Analytical Biochemistry 349:136–147. DOI: https://doi.org/10.1016/j.ab.2005.09.034,
PMID: 16337141
Katoh K, Misawa K, Kuma K, Miyata T. 2002. MAFFT: a novel method for rapid multiple sequence alignment
based on fast Fourier transform. Nucleic Acids Research 30:3059–3066. DOI: https://doi.org/10.1093/nar/
gkf436, PMID: 12136088
Kelley LA, Sternberg MJ. 2009. Protein structure prediction on the web: a case study using the phyre server.
Nature Protocols 4:363–371. DOI: https://doi.org/10.1038/nprot.2009.2, PMID: 19247286
Koropatkin NM, Cameron EA, Martens EC. 2012. How glycan metabolism shapes the human gut microbiota.
Nature Reviews Microbiology 10:323–335. DOI: https://doi.org/10.1038/nrmicro2746, PMID: 22491358
Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, McWilliam H, Valentin F, Wallace IM, Wilm A,
Lopez R, Thompson JD, Gibson TJ, Higgins DG. 2007. Clustal W and clustal X version 2.0. Bioinformatics 23:
2947–2948. DOI: https://doi.org/10.1093/bioinformatics/btm404, PMID: 17846036
Lauber F, Cornelis GR, Renzi F. 2016. Identification of a new lipoprotein export signal in Gram-Negative
Bacteria. mBio 7:16. DOI: https://doi.org/10.1128/mBio.01232-16
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 19 of 20
Research article Microbiology and Infectious Disease
Lu GA. 1996. A WWW service system for automatic comparison of protein structures. Protein Data Bank
Quarterly Newsletter 78:10–11.
Martens EC, Chiang HC, Gordon JI. 2008. Mucosal glycan foraging enhances fitness and transmission of a
saccharolytic human gut bacterial symbiont. Cell Host & Microbe 4:447–457. DOI: https://doi.org/10.1016/j.
chom.2008.09.007, PMID: 18996345
McCaddon A. 2013. Vitamin B12 in neurology and ageing; clinical and genetic aspects. Biochimie 95:1066–1076.
DOI: https://doi.org/10.1016/j.biochi.2012.11.017, PMID: 23228515
Moore E, Mander A, Ames D, Carne R, Sanders K, Watters D. 2012. Cognitive impairment and vitamin B12: a
review. International Psychogeriatrics 24:541–556. DOI: https://doi.org/10.1017/S1041610211002511,
PMID: 22221769
Nielsen MJ, Rasmussen MR, Andersen CB, Nexø E, Moestrup SK. 2012. Vitamin B12 transport from food to the
body’s cells–a sophisticated, multistep pathway. Nature Reviews Gastroenterology & Hepatology 9:345–354.
DOI: https://doi.org/10.1038/nrgastro.2012.76, PMID: 22547309
Obeid R, Fedosov SN, Nexo E. 2015. Cobalamin coenzyme forms are not likely to be superior to cyano- and
hydroxyl-cobalamin in prevention or treatment of cobalamin deficiency. Molecular Nutrition & Food Research
59:1364–1372. DOI: https://doi.org/10.1002/mnfr.201500019, PMID: 25820384
Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2004. UCSF Chimera–a
visualization system for exploratory research and analysis. Journal of Computational Chemistry 25:1605–1612.
DOI: https://doi.org/10.1002/jcc.20084, PMID: 15264254
Ripoll DR, Faerman CH, Axelsen PH, Silman I, Sussman JL. 1993. An electrostatic mechanism for substrate
guidance down the aromatic gorge of acetylcholinesterase. PNAS 90:5128–5132. DOI: https://doi.org/10.1073/
pnas.90.11.5128, PMID: 8506359
Roth JR, Lawrence JG, Rubenfield M, Kieffer-Higgins S, Church GM. 1993. Characterization of the cobalamin
(vitamin B12) biosynthetic genes of Salmonella typhimurium. Journal of Bacteriology 175:3303–3316.
DOI: https://doi.org/10.1128/jb.175.11.3303-3316.1993, PMID: 8501034
Scheithauer TP, Dallinga-Thie GM, de Vos WM, Nieuwdorp M, van Raalte DH. 2016. Causality of small and large
intestinal microbiota in weight regulation and insulin resistance. Molecular Metabolism 5:759–770. DOI: https://
doi.org/10.1016/j.molmet.2016.06.002, PMID: 27617199
Schjo¨nsby H, Drasar BS, Tabaqchali S, Booth CC. 1973. Uptake of vitamin B 12 by intestinal bacteria in the
stagnant loop syndrome. Scandinavian Journal of Gastroenterology 8:41–47. PMID: 4633220
Schjo¨nsby H, Halvorsen JF, Hofstad T, Hovdenak N. 1977. Stagnant loop syndrome in patients with continent
ileostomy (intra-abdominal ileal reservoir). Gut 18:795–799. DOI: https://doi.org/10.1136/gut.18.10.795,
PMID: 590837
Schneider TD, Stephens RM. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids
Research 18:6097–6100. DOI: https://doi.org/10.1093/nar/18.20.6097, PMID: 2172928
Shipman JA, Cho KH, Siegel HA, Salyers AA. 1999. Physiological characterization of SusG, an outer membrane
protein essential for starch utilization by Bacteroides thetaiotaomicron. Journal of Bacteriology 181:7206–7211.
PMID: 10572122
Shipman JA, Berleman JE, Salyers AA. 2000. Characterization of four outer membrane proteins involved in
binding starch to the cell surface of Bacteroides thetaiotaomicron. Journal of Bacteriology 182:5365–5372.
DOI: https://doi.org/10.1128/JB.182.19.5365-5372.2000, PMID: 10986238
Sonnenburg JL, Xu J, Leip DD, Chen CH, Westover BP, Weatherford J, Buhler JD, Gordon JI. 2005. Glycan
foraging in vivo by an intestine-adapted bacterial symbiont. Science 307:1955–1959. DOI: https://doi.org/10.
1126/science.1109051, PMID: 15790854
Sonnenburg ED, Sonnenburg JL. 2014. Gut microbes take their vitamins. Cell Host & Microbe 15:5–6.
DOI: https://doi.org/10.1016/j.chom.2013.12.011, PMID: 24439893
Tan RC, Truong TN, McCammon JA, Sussman JL. 1993. Acetylcholinesterase: electrostatic steering increases the
rate of ligand binding. Biochemistry 32:401–403. DOI: https://doi.org/10.1021/bi00053a003, PMID: 8422348
Truett GE, Heeger P, Mynatt RL, Truett AA, Walker JA, Warman ML. 2000. Preparation of PCR-quality mouse
genomic DNA with hot sodium hydroxide and tris (HotSHOT). BioTechniques 29:52–54. DOI: https://doi.org/
10.2144/00291bm09, PMID: 10907076
von Heijne G. 1989. The structure of signal peptides from bacterial lipoproteins. "Protein Engineering, Design
and Selection" 2:531–534. DOI: https://doi.org/10.1093/protein/2.7.531
Whitman WB, Coleman DC, Wiebe WJ. 1998. Prokaryotes: the unseen majority. PNAS 95:6578–6583.
DOI: https://doi.org/10.1073/pnas.95.12.6578, PMID: 9618454
Young DB, Comas I, de Carvalho LP. 2015. Phylogenetic analysis of vitamin B12-related metabolism in
Mycobacterium tuberculosis. Frontiers in Molecular Biosciences 2:6. DOI: https://doi.org/10.3389/fmolb.2015.
00006, PMID: 25988174
Wexler et al. eLife 2018;7:e37138. DOI: https://doi.org/10.7554/eLife.37138 20 of 20
Research article Microbiology and Infectious Disease
